Renal safety and angiotensin II blockade medications in patients undergoing non-emergent coronary angiography: A randomized controlled study

Keyphrases

• Randomized Controlled Study 100%
• Estimated Glomerular Filtration Rate 100%
• Coronary Angiography 100%
• Renin-angiotensin System Blockade 100%
• Renal Safety 100%
• Non-emergent 100%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 16%
• Contrast-induced Nephropathy 16%
• Difference in Estimated Glomerular Filtration Rate 16%
• No Significant Difference 8%
• Randomized Controlled Trial 8%
• Renal Failure 8%
• Hospitalized Patients 8%
• Endpoint Analysis 8%
• Angiography 8%
• Blocking Agent 8%
• Contrast Study 8%
• New Onset 8%
• Plasma Creatinine 8%
• Renin-angiotensin-aldosterone System 8%
• System Blocking 8%
• Background Contrast 8%
• Cockroft-Gault 8%
• Diabetes Mellitus 8%

Medicine and Dentistry

• Glomerular Filtration Rate 100%
• Angiotensin II 100%
• Coronary Angiography 100%
• Contrast-Induced Nephropathy 15%
• Diabetes Mellitus 7%
• Renal Failure 7%
• Randomized Controlled Trial 7%
• Post-Hoc Analysis 7%
• Angiography 7%
• Creatinine 7%
• ACE Inhibitor 7%
• Angiotensin Receptor Antagonist 7%
• Renin Angiotensin Aldosterone System 7%
• Blocking Agent 7%

Nursing and Health Professions

• Receiving Treatment 7%